Bambusa Therapeutics (BBTX) stock

Medicines for inflammation , market cap $807M

Medicines for chronic inflammation

Worth $807M

$17.00

+0.35%

As of 10:26 AM ET, delayed 15+ min · Live for Pro members

Quality Score

New listing

Checks firing

2of 14

Transition

From its high

-2.4%

under its best since listing

BBTX's Quality Score rose 2 points on Mon, Nov 9, to 3. It closed near its high of the day (2 chart checks started).

Trading since Oct 30, 2026. 8 trading days so far, so 11 of the 14 chart checks wait for more history.

Follow BBTX's trial news. Pro members can get an alert when Bambusa Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when BBTX files news on its trialsSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on BBTX

Key facts on BBTX
Latest filing	8-K, Nov 3 Changed its bylaws or fiscal year

BBTX catalysts

Coming up

What's next for BBTX

Its trials

A trial underway: Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous UrticariaPhase 1/2 · Recruiting · 48 people · main data estimated Dec 31, 2027 · NCT07717905

5 more trials, 1 with data due this year, 1 filing, for Pro members.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

Director RA CAPITAL MANAGEMENT, L.P. bought 2,953,820 shares on Nov 2. 1 more insider trade this year.

From Form 4: open-market buys and sales only.

Get an alert when Shanshan Xu buys or sells

For Pro members: every trade, and Shanshan Xu’s 3 filings and quotes.

Get an alert when BBTX files news on its trialsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

Why BBTX scores 3

New listingfor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

+2Chart checks 2 of 14 firing right now, one point each
+1Insider trades Salvia Investment GmbH (10% owner) bought $6M on Nov 2, and 5 more filings

No effect today: Long-term trend, Run-up, Size, Profit, Growth, Dilution, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on BBTX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:26 AM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when BBTX's Quality Score turns up

A free account. No card.

How BBTX ranks in Biotech

BBTX is a new listing, ranked from its 22nd trading day.

How BBTX ranks in Biotech
Rank	Stock	Checks	Quality Score
1	ONCBeOne Medicines	8/14	24
2	VCELVericel	9/14	23
3	XERSXeris Biopharma	9/14	22
	BBIOBridgeBio Pharma		Open for its score
	BBOTBridgeBio Oncology Therapeutics		Open for its score
	BCAXBicara Therapeutics		Open for its score
	BCYCBicycle Therapeutics		Open for its score
New	BBTXBambusa Therapeutics	2/14	3

BBTX has 2 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on BBTX, and all 14 on every stock.Get in free →

The deep dive on BBTX

What it does and how it makes money1 findingFor Pro members1 finding on what BBTX does and how it makes money, for Pro members
Who holds and trades it1 findingInsiders bought $52.6M of shares on the open market in 90 days, with no sales; the largest, 10% owner RA Capital Management, L.P., bought $37.4M on Nov 2, 2026.Form 4, filed Nov 3, 2026

BBTX share count over time

Offerings, shelves, and splits of BBTX, from its filings
From its filings	Filed
Raised $168.9M in a sale of shares, about 21% of its market value	Oct 30, 2026
Registered shares for sale (S-1)	Oct 9, 2026

BBTX insider trades

2 insiders bought $52.6M across 5 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuyRA Capital Management, L.P.$37.4M10% ownerat $16.00 on Nov 2, filed Nov 3

BuyRA Capital Management, L.P.10% owner$37.4Mat $16.00 on Nov 2, filed Nov 3

All 5 insider filings on BBTX from the last six months, for Pro members.

All BBTX insider trades

BBTX's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Shanshan XuOfficer · no trades on file

See insider trades by person

About Bambusa Therapeutics

Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.

bambusatx.com

Listed on Nasdaq on Oct 30, 2026, and is 6.3% above its $16 offer price now. Its IPO filing and first days

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on BBTX and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would turn BBTX's score around: 1 thing
2 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayNov 3RA Capital Management, L.P. bought BBTX$37.4M at $16.00, filed Nov 3

Alerts are optional.

See BBTX's 14 chart checks

See it live, free for 24 hours. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: BBTX's Quality Score is 3 (New listing). Insiders bought $52.6M in the last 6 months (Form 4).

What does BBTX's Quality Score say?

BBTX scores 3 today, which Breakaway calls Below Average. It has 2 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is BBTX's Quality Score?

BBTX scores 3 today, which Breakaway calls Below Average (0 to 5). The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BBTX's 3.

Are insiders buying BBTX?

2 insiders bought $52.6M across 5 filings in the last 6 months. No open-⁠market sales on record. The newest is RA Capital Management, L.P., 10% owner, who bought $37.4M on Nov 2. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.